ChemICare https://www.chemicare.it/ It’s a rare thing to care Wed, 20 May 2026 13:30:04 +0000 it-IT hourly 1 https://wordpress.org/?v=7.1.3 https://www.chemicare.it/wp/wp-content/uploads/2022/02/cropped-favicon-chemicare-32x32.png ChemICare https://www.chemicare.it/ 32 32 ChemiCare Raises € 2.5 M Seed Round for the Development of a New Drug Candidate https://www.chemicare.it/news/chemicare-raises-e-2-5-m-seed-round-for-the-development-of-a-new-drug-candidate/ https://www.chemicare.it/news/chemicare-raises-e-2-5-m-seed-round-for-the-development-of-a-new-drug-candidate/#respond Fri, 19 Dec 2025 09:00:00 +0000 https://www.chemicare.it/?p=773 ChemiCare, spin-off of the University of Piemonte Orientale (UPO), has closed a € 2.5 million investment round subscribed by CDP Venture Capital SGR S.p.A., Bio4Dreams S.p.A. and Bridge4Pharma S.r.l. with the aim of progressing its internal pipeline.

L'articolo ChemiCare Raises € 2.5 M Seed Round for the Development of a New Drug Candidate proviene da ChemICare.

]]> ChemiCare, spin-off of the University of Piemonte Orientale (UPO), has closed a € 2.5 million investment round subscribed by CDP Venture Capital SGR S.p.A., Bio4Dreams S.p.A. and Bridge4Pharma S.r.l. with the aim of progressing its internal pipeline.

L'articolo ChemiCare Raises € 2.5 M Seed Round for the Development of a New Drug Candidate proviene da ChemICare.

]]> https://www.chemicare.it/news/chemicare-raises-e-2-5-m-seed-round-for-the-development-of-a-new-drug-candidate/feed/ 0 ChemiCare, UPO and AOU “Maggiore della Carità” together against multiple sclerosis https://www.chemicare.it/news/chemicare-upo-aou-maggioredellacarita-together-against-multiple-sclerosis/ https://www.chemicare.it/news/chemicare-upo-aou-maggioredellacarita-together-against-multiple-sclerosis/#respond Wed, 12 Feb 2025 12:35:18 +0000 https://www.chemicare.it/?p=685 Funded by the Italian Multiple Sclerosis Foundation, the STOP-MS project is a multicenter study involving the Multiple Sclerosis Center of the “Maggiore della Carità” University Hospital and the Immunomics Laboratory at CAAD, part of the Department of Health Sciences at UPO.

L'articolo ChemiCare, UPO and AOU “Maggiore della Carità” together against multiple sclerosis proviene da ChemICare.

]]> Together with this alliance, Bridge4Pharma S.r.l., decided to invest in ChemiCare S.r.l.

Funded by the Italian Multiple Sclerosis Foundation, the STOP-MS project is a multicenter study involving the Multiple Sclerosis Center of the “Maggiore della Carità” University Hospital and the Immunomics Laboratory at CAAD, part of the Department of Health Sciences at UPO.

L'articolo ChemiCare, UPO and AOU “Maggiore della Carità” together against multiple sclerosis proviene da ChemICare.

]]> https://www.chemicare.it/news/chemicare-upo-aou-maggioredellacarita-together-against-multiple-sclerosis/feed/ 0 ChemiCare drug candidate CIC-39 received the FDA orphan drug designation for Duchenne Muscular Dystrophy. https://www.chemicare.it/news/chemicare-drug-candidate-cic-39-received-the-fda-orphan-drug-designation-for-duchenne-muscular-dystrophy/ https://www.chemicare.it/news/chemicare-drug-candidate-cic-39-received-the-fda-orphan-drug-designation-for-duchenne-muscular-dystrophy/#respond Tue, 24 Sep 2024 13:38:12 +0000 https://www.chemicare.it/?p=639 Food and Drug Administration

L'articolo ChemiCare drug candidate CIC-39 received the FDA orphan drug designation for Duchenne Muscular Dystrophy. proviene da ChemICare.

]]> Food and Drug Administration

L'articolo ChemiCare drug candidate CIC-39 received the FDA orphan drug designation for Duchenne Muscular Dystrophy. proviene da ChemICare.

]]> https://www.chemicare.it/news/chemicare-drug-candidate-cic-39-received-the-fda-orphan-drug-designation-for-duchenne-muscular-dystrophy/feed/ 0 Beatrice Riva among the InspiringFifty Italy 2024 Winners. https://www.chemicare.it/news/inspiringfifty-italy-2024-chemicare/ Tue, 10 Sep 2024 09:54:27 +0000 https://www.chemicare.it/?p=633 Beatrice Riva, CEO of ChemiCare, was among the fifty women recognized as role models this year by InspiringFifty Italy 2024.

L'articolo Beatrice Riva among the InspiringFifty Italy 2024 Winners. proviene da ChemICare.

]]> InspiringFifty is dedicated to promoting gender diversity in the fields of technology and innovation.

L'articolo Beatrice Riva among the InspiringFifty Italy 2024 Winners. proviene da ChemICare.

]]> ChemiCare in Silicon Valley for CALL4INNOVIT. https://www.chemicare.it/news/chemicare-in-silicon-valley-for-call4innovit/ Mon, 24 Jun 2024 15:51:15 +0000 https://www.chemicare.it/?p=611 ChemiCare was selected by INNOVIT - Italian Innovation and Culture Hub to take part at CALL4INNOVIT, the acceleration program dedicated to startup and scaleups in Life Sciences & Digital Health.

L'articolo ChemiCare in Silicon Valley for CALL4INNOVIT. proviene da ChemICare.

]]> ChemiCare selected by INNOVIT – Italian Innovation and Culture Hub to take part at CALL4INNOVIT, the Acceleration Program dedicated to startup and scaleups in Life Sciences & Digital Health.

L'articolo ChemiCare in Silicon Valley for CALL4INNOVIT. proviene da ChemICare.

]]> ChemiCare and Bridge4Pharma are joining forces into a partnership to push forward the development of pipeline initiatives. https://www.chemicare.it/news/chemicare-bridge4pharma_partnership/ https://www.chemicare.it/news/chemicare-bridge4pharma_partnership/#respond Tue, 30 Jan 2024 12:10:46 +0000 https://www.chemicare.it/?p=586 Together with this alliance, Bridge4Pharma S.r.l., decided to invest in ChemiCare S.r.l.

L'articolo ChemiCare and Bridge4Pharma are joining forces into a partnership to push forward the development of pipeline initiatives. proviene da ChemICare.

]]> Together with this alliance, Bridge4Pharma S.r.l., decided to invest in ChemiCare S.r.l.

Bridge4Pharma, a company focused on supporting research and development projects and activities based on diagnostic, therapeutic and medical device technologies, will strategically support ChemiCare operations in preclinical and clinical drug development.

L'articolo ChemiCare and Bridge4Pharma are joining forces into a partnership to push forward the development of pipeline initiatives. proviene da ChemICare.

]]> https://www.chemicare.it/news/chemicare-bridge4pharma_partnership/feed/ 0 ChemiCare has received the award “America Innovazione” https://www.chemicare.it/news/chemicare-received-award-america-innovazione/ https://www.chemicare.it/news/chemicare-received-award-america-innovazione/#respond Mon, 08 May 2023 10:53:49 +0000 https://www.chemicare.it/?p=501 Corriere della Sera

L'articolo ChemiCare has received the award “America Innovazione” proviene da ChemICare.

]]> Corriere della Sera

L'articolo ChemiCare has received the award “America Innovazione” proviene da ChemICare.

]]> https://www.chemicare.it/news/chemicare-received-award-america-innovazione/feed/ 0 ChemiCare drug candidate CIC-39 received the EMA orphan drug designation for Duchenne Muscular Dystrophy. https://www.chemicare.it/news/chemicare-drug-candidate-cic-39-received-the-ema-orphan-drug-designation-for-duchenne-muscular-dystrophy/ https://www.chemicare.it/news/chemicare-drug-candidate-cic-39-received-the-ema-orphan-drug-designation-for-duchenne-muscular-dystrophy/#respond Thu, 08 Dec 2022 09:48:17 +0000 https://www.chemicare.it/?p=481 European Medicine Agency

L'articolo ChemiCare drug candidate CIC-39 received the EMA orphan drug designation for Duchenne Muscular Dystrophy. proviene da ChemICare.

]]> European Medicine Agency

L'articolo ChemiCare drug candidate CIC-39 received the EMA orphan drug designation for Duchenne Muscular Dystrophy. proviene da ChemICare.

]]> https://www.chemicare.it/news/chemicare-drug-candidate-cic-39-received-the-ema-orphan-drug-designation-for-duchenne-muscular-dystrophy/feed/ 0 ChemiCare drug candidate CIC-39 received the EMA orphan drug designation for TAM and other calcium-related disease. https://www.chemicare.it/news/cic-39-designazione-ema-di-farmaco-orfano-per-tam-malattie-rare-calcio/ https://www.chemicare.it/news/cic-39-designazione-ema-di-farmaco-orfano-per-tam-malattie-rare-calcio/#respond Thu, 12 May 2022 14:14:00 +0000 https://www.chemicare.it/?p=409 European Medicine Agency

L'articolo ChemiCare drug candidate CIC-39 received the EMA orphan drug designation for TAM and other calcium-related disease. proviene da ChemICare.

]]> European Medicine Agency

L'articolo ChemiCare drug candidate CIC-39 received the EMA orphan drug designation for TAM and other calcium-related disease. proviene da ChemICare.

]]> https://www.chemicare.it/news/cic-39-designazione-ema-di-farmaco-orfano-per-tam-malattie-rare-calcio/feed/ 0 Modulatori del SOCE, composizioni e loro usi https://www.chemicare.it/news/modulatori-del-soce-composizioni-e-loro-usi/ https://www.chemicare.it/news/modulatori-del-soce-composizioni-e-loro-usi/#respond Fri, 19 Nov 2021 14:25:58 +0000 https://www.chemicare.it/wp/?p=308 Università del Piemonte Orientale

L'articolo Modulatori del SOCE, composizioni e loro usi proviene da ChemICare.

]]> Università del Piemonte Orientale

L'articolo Modulatori del SOCE, composizioni e loro usi proviene da ChemICare.

]]> https://www.chemicare.it/news/modulatori-del-soce-composizioni-e-loro-usi/feed/ 0